Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson's disease

Per Borghammer, Paul Cumming, Joel Aanerud, Albert Gjedde

Research output: Contribution to journalArticle

Abstract

Aim: Recent studies of Parkinson's disease (PD) report subcortical increases of cerebral blood flow (CBF) or cerebral metabolic rate of glucose (CMRglc), after conventional normalization to the global mean. However, if the global mean CBF or CMRglc is decreased in the PD group, this normalization necessarily generates artificial relative increases in regions unaffected by the disease. This potential bias may explain the reported subcortical increases in PD. To test this hypothesis, we performed simulations with manipulation and subsequently analysis of sets of quantitative CBF maps by voxel-based statistics. Materials and methods: CBF images from 49 healthy volunteers were randomly assigned to four sets of two groups of 20 subjects. For each set, CBF images in one group were manipulated, while the other group served as controls. In the first simulation, an isolated cortical decrease was simulated. In the second simulation, focal increases in the globus pallidus and thalamus motor nuclei were simulated in addition to cortical decreases, thus emulating the putative metabolic pattern in PD. The data were analyzed with both the SSM method and a univariate statistical approach with normalization to either the global mean or to the white matter mean. Results: In Simulation I, global normalization robustly created artefactual subcortical increases, irrespective of analysis methodology. Simulation II demonstrated that an increased signal from the small subcortical structures involved in PD can probably not be detected with present instrumentation and typically-used sample sizes. Conclusion: Imposing focal decreases on cortical CBF in conjunction with global mean normalization gives rise to spurious relative CBF increases in all of the regions reported to be hyperactive in PD. Since no PET study has reported absolute increases of CBF or CMRglc in any subcortical region in PD, we conclude that the relative increases reported in some studies most likely arise from biased normalization to the global mean.

Original languageEnglish (US)
Pages (from-to)249-257
Number of pages9
JournalNeuroImage
Volume45
Issue number2
DOIs
StatePublished - Apr 1 2009
Externally publishedYes

Fingerprint

Cerebrovascular Circulation
Parkinson Disease
Glucose
Globus Pallidus
Thalamus
Sample Size
Healthy Volunteers

Keywords

  • CBF
  • Energy metabolism
  • Normalization
  • Parkinson's disease
  • White matter

ASJC Scopus subject areas

  • Cognitive Neuroscience
  • Neurology

Cite this

Artefactual subcortical hyperperfusion in PET studies normalized to global mean : Lessons from Parkinson's disease. / Borghammer, Per; Cumming, Paul; Aanerud, Joel; Gjedde, Albert.

In: NeuroImage, Vol. 45, No. 2, 01.04.2009, p. 249-257.

Research output: Contribution to journalArticle

Borghammer, Per ; Cumming, Paul ; Aanerud, Joel ; Gjedde, Albert. / Artefactual subcortical hyperperfusion in PET studies normalized to global mean : Lessons from Parkinson's disease. In: NeuroImage. 2009 ; Vol. 45, No. 2. pp. 249-257.
@article{e2b558afc0bb4794bedf99b81334945a,
title = "Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson's disease",
abstract = "Aim: Recent studies of Parkinson's disease (PD) report subcortical increases of cerebral blood flow (CBF) or cerebral metabolic rate of glucose (CMRglc), after conventional normalization to the global mean. However, if the global mean CBF or CMRglc is decreased in the PD group, this normalization necessarily generates artificial relative increases in regions unaffected by the disease. This potential bias may explain the reported subcortical increases in PD. To test this hypothesis, we performed simulations with manipulation and subsequently analysis of sets of quantitative CBF maps by voxel-based statistics. Materials and methods: CBF images from 49 healthy volunteers were randomly assigned to four sets of two groups of 20 subjects. For each set, CBF images in one group were manipulated, while the other group served as controls. In the first simulation, an isolated cortical decrease was simulated. In the second simulation, focal increases in the globus pallidus and thalamus motor nuclei were simulated in addition to cortical decreases, thus emulating the putative metabolic pattern in PD. The data were analyzed with both the SSM method and a univariate statistical approach with normalization to either the global mean or to the white matter mean. Results: In Simulation I, global normalization robustly created artefactual subcortical increases, irrespective of analysis methodology. Simulation II demonstrated that an increased signal from the small subcortical structures involved in PD can probably not be detected with present instrumentation and typically-used sample sizes. Conclusion: Imposing focal decreases on cortical CBF in conjunction with global mean normalization gives rise to spurious relative CBF increases in all of the regions reported to be hyperactive in PD. Since no PET study has reported absolute increases of CBF or CMRglc in any subcortical region in PD, we conclude that the relative increases reported in some studies most likely arise from biased normalization to the global mean.",
keywords = "CBF, Energy metabolism, Normalization, Parkinson's disease, White matter",
author = "Per Borghammer and Paul Cumming and Joel Aanerud and Albert Gjedde",
year = "2009",
month = "4",
day = "1",
doi = "10.1016/j.neuroimage.2008.07.042",
language = "English (US)",
volume = "45",
pages = "249--257",
journal = "NeuroImage",
issn = "1053-8119",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Artefactual subcortical hyperperfusion in PET studies normalized to global mean

T2 - Lessons from Parkinson's disease

AU - Borghammer, Per

AU - Cumming, Paul

AU - Aanerud, Joel

AU - Gjedde, Albert

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Aim: Recent studies of Parkinson's disease (PD) report subcortical increases of cerebral blood flow (CBF) or cerebral metabolic rate of glucose (CMRglc), after conventional normalization to the global mean. However, if the global mean CBF or CMRglc is decreased in the PD group, this normalization necessarily generates artificial relative increases in regions unaffected by the disease. This potential bias may explain the reported subcortical increases in PD. To test this hypothesis, we performed simulations with manipulation and subsequently analysis of sets of quantitative CBF maps by voxel-based statistics. Materials and methods: CBF images from 49 healthy volunteers were randomly assigned to four sets of two groups of 20 subjects. For each set, CBF images in one group were manipulated, while the other group served as controls. In the first simulation, an isolated cortical decrease was simulated. In the second simulation, focal increases in the globus pallidus and thalamus motor nuclei were simulated in addition to cortical decreases, thus emulating the putative metabolic pattern in PD. The data were analyzed with both the SSM method and a univariate statistical approach with normalization to either the global mean or to the white matter mean. Results: In Simulation I, global normalization robustly created artefactual subcortical increases, irrespective of analysis methodology. Simulation II demonstrated that an increased signal from the small subcortical structures involved in PD can probably not be detected with present instrumentation and typically-used sample sizes. Conclusion: Imposing focal decreases on cortical CBF in conjunction with global mean normalization gives rise to spurious relative CBF increases in all of the regions reported to be hyperactive in PD. Since no PET study has reported absolute increases of CBF or CMRglc in any subcortical region in PD, we conclude that the relative increases reported in some studies most likely arise from biased normalization to the global mean.

AB - Aim: Recent studies of Parkinson's disease (PD) report subcortical increases of cerebral blood flow (CBF) or cerebral metabolic rate of glucose (CMRglc), after conventional normalization to the global mean. However, if the global mean CBF or CMRglc is decreased in the PD group, this normalization necessarily generates artificial relative increases in regions unaffected by the disease. This potential bias may explain the reported subcortical increases in PD. To test this hypothesis, we performed simulations with manipulation and subsequently analysis of sets of quantitative CBF maps by voxel-based statistics. Materials and methods: CBF images from 49 healthy volunteers were randomly assigned to four sets of two groups of 20 subjects. For each set, CBF images in one group were manipulated, while the other group served as controls. In the first simulation, an isolated cortical decrease was simulated. In the second simulation, focal increases in the globus pallidus and thalamus motor nuclei were simulated in addition to cortical decreases, thus emulating the putative metabolic pattern in PD. The data were analyzed with both the SSM method and a univariate statistical approach with normalization to either the global mean or to the white matter mean. Results: In Simulation I, global normalization robustly created artefactual subcortical increases, irrespective of analysis methodology. Simulation II demonstrated that an increased signal from the small subcortical structures involved in PD can probably not be detected with present instrumentation and typically-used sample sizes. Conclusion: Imposing focal decreases on cortical CBF in conjunction with global mean normalization gives rise to spurious relative CBF increases in all of the regions reported to be hyperactive in PD. Since no PET study has reported absolute increases of CBF or CMRglc in any subcortical region in PD, we conclude that the relative increases reported in some studies most likely arise from biased normalization to the global mean.

KW - CBF

KW - Energy metabolism

KW - Normalization

KW - Parkinson's disease

KW - White matter

UR - http://www.scopus.com/inward/record.url?scp=60149100589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60149100589&partnerID=8YFLogxK

U2 - 10.1016/j.neuroimage.2008.07.042

DO - 10.1016/j.neuroimage.2008.07.042

M3 - Article

C2 - 18718541

AN - SCOPUS:60149100589

VL - 45

SP - 249

EP - 257

JO - NeuroImage

JF - NeuroImage

SN - 1053-8119

IS - 2

ER -